According to Gate News bot, as reported by BlockBeats, on July 1st, the CFX price experienced significant Fluctuation. Influenced by the news of “Pioneer Pharmaceuticals’ acquisition of all shares of Conflux”, CFX rose by more than 10% at one point. The price then retreated, and the current trading price is $0.0788, with a total market capitalization of $387 million. It is reported that Pioneer Pharmaceuticals and Conflux have signed a memorandum of understanding and are discussing potential acquisition matters.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
CFX short-term pump over 10%, total market capitalization reaches 387 million USD
According to Gate News bot, as reported by BlockBeats, on July 1st, the CFX price experienced significant Fluctuation. Influenced by the news of “Pioneer Pharmaceuticals’ acquisition of all shares of Conflux”, CFX rose by more than 10% at one point. The price then retreated, and the current trading price is $0.0788, with a total market capitalization of $387 million. It is reported that Pioneer Pharmaceuticals and Conflux have signed a memorandum of understanding and are discussing potential acquisition matters.